Diabetogenic potential of human pathogens uncovered in experimentally permissive β-cells

Diabetes

Volumn 52, Issue 8, 2003, Pages 2025-2034

  Flodström, Malin ^b   Tsai, Devin ^c   Fine, Cody ^c   Maday, Amy ^c   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; COXSACKIE VIRUS B4; CYTOMEGALOVIRUS; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; IMMUNE RESPONSE; INSULITIS; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; VIROGENESIS; VIRUS MENINGITIS;

ACUTE DISEASE; ANIMALS; ARENAVIRIDAE INFECTIONS; CARRIER PROTEINS; CYTOMEGALOVIRUS INFECTIONS; DIABETES MELLITUS, TYPE 1; HERPESVIRIDAE INFECTIONS; HUMANS; INTERFERONS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; MUROMEGALOVIRUS; MYOCARDITIS; PANCREATITIS; REPRESSOR PROTEINS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; T-LYMPHOCYTES;

EID: 0042266289     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.8.2025     Document Type: Article

References (60)

1. Atkinson MA, Eisenbarth GS: Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221-229, 2001
2. Jaeckel E, Manns M, Von Herrath M: Viruses and diabetes. Ann N Y Acad Sci 958:7-25, 2002
3. Flodström M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N: Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 3:373-382, 2002
4. Yoon JW, Jun HS: Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus. Ann N Y Acad Sci 928:200-211, 2001
5. Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M: Environmental factors in the etiology of type 1 diabetes. Am J Med Genet 115:18-29, 2002
6. Yoon JW, Austin M, Onodera T, Notkins AL: Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300:1173-1179, 1979
7. Champsaur H, Dussaix E, Samolyk D, Fabre M, Bach C, Assan R: Diabetes and Coxsackie virus B5 infection. Lancet 1:251, 1980
8. Iwasaki T, Monma N, Satodate R, Kawana R, Kurata T: An immunofluorescent study of generalized Coxsackie virus B3 infection in a newborn infant. Acta Pathol Jpn 35:741-748, 1985
9. Nigro G, Pacella ME, Patane E, Midulla M: Multi-system coxsackievirus B-6 infection with findings suggestive of diabetes mellitus. Eur J Pediatr 145:557-559, 1986
10. Vreugdenhil GR, Schloot NC, Hoorens A, Rongen C, Pipeleers DG, Melchers WJ, Roep BO, Galama JM: Acute onset of type I diabetes mellitus after severe echovirus 9 infection: putative pathogenic pathways. Clin Infect Dis 31:1025-1031, 2000
11. Gladisch R, Hofmann W, Waldherr R: Myocarditis and insulitis following coxsackie virus infection. Z Kardiol 65:837-849, 1976
12. Jenson AB, Rosenberg HS, Notkins AL: Pancreatic islet-cell damage in children with fatal viral infections. Lancet 2:354-358, 1980
13. Yoon JW, Onodera T, Jenson AB, Notkins AL: Virus-induced diabetes mellitus. XI. Replication of coxsackie B3 virus in human pancreatic beta cell cultures. Diabetes 27:778-781, 1978
14. Szopa TM, Dronfield DM, Ward T, Taylor KW: In vivo infection of mice with Coxsackie B4 virus induces long-term functional changes in pancreatic islets with minimal alteration in blood glucose. Diabet Med 6:314-319, 1989
15. Szopa TM, Gamble DR, Taylor KW: Coxsackie B4 virus induces short-term changes in the metabolic functions of mouse pancreatic islets in vitro. Cell Biochem Funct 4:181-187, 1986
16. Frisk G, Grapengiesser E, Diderholm H: Impaired Ca2+ response to glucose in mouse beta-cells infected with coxsackie B or Echo virus. Virus Res 33:229-240, 1994
17. Frisk G, Diderholm H: Tissue culture of isolated human pancreatic islets infected with different strains of coxsackievirus B4: assessment of virus replication and effects on islet morphology and insulin release. Int J Exp Diabetes Res 1:165-175, 2000
18. Roivainen M, Rasilainen S, Ylipaasto P, Nissinen R, Ustinov J, Bouwens L, Eizirik DL, Hovi T, Otonkoski T: Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab 85:432-440, 2000
19. Roivainen M, Ylipaasto P, Savolainen C, Galama J, Hovi T, Otonkoski T: Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 45:693-702, 2002
20. Cooney RN: Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway. Shock 17:83-90, 2002
21. Chehadeh W, Kerr-Conte J, Pattou F, Alm G, Lefebvre J, Wattre P, Hober D: Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol 74:10153-10164, 2000
22. Buchmeier MJ, Zajac AJ: Lymphocytic Choriomeningitis Virus. In Persistent Viral Infections. Ahmed R, Chen I, Eds. New York, John Wiley & Sons, 1999, p. 575-605
23. Price P, Olver SD: Syndromes induced by cytomegalovirus infection. Clin Immunol Immunopathol 80:215-224, 1996
24. Tarr GC, Armstrong JA, Ho M: Production of interferon and serum hyporeactivity factor in mice infected with murine cytomegalovirus. Infect Immun 19:903-907, 1978
25. Kelsey DK, Overall JC Jr, Glasgow LA: Production of alpha and gamma interferons by spleen cells from cytomegalovirus-infected mice. Infect Immun 36:651-656, 1982
26. Heise MT, Pollock JL, O'Guin A, Barkon ML, Bormley S, Virgin HW 4th: Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon. Virology 241:331-344, 1998
27. Cebulla CM, Miller DM, Sedmak DD: Viral inhibition of interferon signal transduction. Intervirology 42:325-330, 1999
28. Andreoletti L, Hober D, Hober-Vandenberghe C, Fajardy I, Belaich S, Lambert V, Vantyghem MC, Lefebvre J, Wattre P: Coxsackie B virus infection and beta cell autoantibodies in newly diagnosed IDDM adult patients. Clin Diagn Virol 9:125-133, 1998
29. Roivainen M, Knip M, Hyoty H, Kulmala P, Hiltunen M, Vahasalo P, Hovi T, Akerblom HK: Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM: Childhood Diabetes in Finland (DiMe) Study Group. JMed Virol 56:74-78, 1998
30. Horwitz MS, La Cava A, Fine C, Rodriguez E, Ihc A, Sarvetnick N: Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med 6:693-697, 2000
31. Tracy S, Drescher KM, Chapman NM, Kim KS, Carson SD, Pirruccello S, Lane PH, Romero JR, Leser JS: Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 76:12097-12111, 2002
32. Mena I, Fischer C, Gebhard JR, Perry CM, Harkins S, Whitton JL: Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology 271:276-288, 2000
33. Kandolf R, Canu A, Hofschneider PH: Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J Mol Cell Cardiol 17:167-181, 1985
34. Heim A, Canu A, Kirschner P, Simon T, Mall G, Hofschneider PH, Kandolf R: Synergistic interaction of interferon-beta and interferon-gamma in coxsackievirus B3-infected carrier cultures of human myocardial fibro-flbroblasts. J Infect Dis 166:958-965, 1992
35. Lutton CW, Gauntt CJ: Ameliorating effect of IFN-beta and anti-IFN-beta on coxsackievirus B3-induced myocarditis in mice. J Interferon Res 5:137-146, 1985
36. Matsumori A, Tomioka N, Kawai C: Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice. Am Heart J 115:1229-1232, 1988
37. Wessely R, Klingel K, Knowlton KU, Kandolf R: Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation 103:756-761, 2001
38. Angulo A, Chandraratna RA, LeBlanc JF, Ghazal P: Ligand induction of retinoic acid receptors alters an acute infection by murine cytomegalovirus. J Virol 72:4589-4600, 1998
39. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N: Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 4:781-785, 1998
40. Flodström M, Tyrberg B, Eizirik DL, Sandler S: Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes 48:706-713, 1999
41. Serreze DV, Leiter EH: Genes and cellular requirements for autoimmune diabetes susceptibility in nonobese diabetic mice. Curr Dir Autoimmun 4:31-67, 2001
42. Fazakerley JK, Southern P, Bloom F, Buchmeier MJ: High resolution in situ hybridization to determine the cellular distribution of lymphocytic choriomeningitis virus RNA in the tissues of persistently infected mice: relevance to arenavirus disease and mechanisms of viral persistence. J Gen Virol 72:1611-1625, 1991
43. Allan JE, Shellam GR: Characterization of interferon induction in mice of resistant and susceptible strains during murine cytomegalovirus infection. J Gen Virol 66:1105-1112, 1985
44. Price P, Baxter AG, Allcock RN, Papadimitriou JM: Factors influencing the effects of murine cytomegalovirus on the pancreas. Eur J Clin Invest 28:546-553, 1998
45. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, et al.: Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154:180-191, 1995
46. Alexander WS: Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2:410-416, 2002
47. von Herrath MG: Regulation of virally induced autoimmunity and immunopathology: contribution of LCMV transgenic models to understanding autoimmune insulin-dependent diabetes mellitus. Curr Top Microbiol Immunol 263:145-175, 2002
48. Oldstone MB, Southern P, Rodriquez M, Lampert P: Virus persists in beta cells of islets of Langerhans and is associated with chemical manifestations of diabetes. Science 224:1440-1443, 1984
49. Rodriguez M, Garrett RS, Raitt M, Lampert PW, Oldstone MB: Virus persists in beta cells of islets of Langerhans and infection is associated with chemical manifestations of diabetes. II. Morphologic observations. Am J Pathol 121:497-504, 1985
50. Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, Nichol ST, Compans RW, Campbell KP, Oldstone MB: Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282:2079-2081, 1998
51. Smelt SC, Borrow P, Kunz S, Cao W, Tishon A, Lewicki H, Campbell KP, Oldstone MB: Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics. J Virol 75:448-457, 2001
52. Durbeej M, Henry MD, Ferletta M, Campbell KP, Ekblom P: Distribution of dystroglycan in normal adult mouse tissues. J Histochem Cytochem 46:449-457, 1998
53. Nicoletti F, Scalia G, Lunetta M, Condorelli F, Di Mauro M, Barcellini W, Stracuzzi S, Pagano M, Meroni PL: Correlation between islet cell antibodies and anti-cytomegalovirus IgM and IgG antibodies in healthy first-degree relatives of type 1 (insulin-dependent) diabetic patients. Clin Immunol Immunopathol 55:139-147, 1990
54. Pak CY, Eun HM, McArthur RG, Yoon JW: Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 2:1-4, 1988
55. Hiemstra HS, Schloot NC, van Veelen PA, WiUemen SJ, Franken KL, van Rood JJ, de Vries RR, Chaudhuri A, Behan PO, Drijfhout JW, Roep BO: Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A 98:3988-3991, 2001
56. Numazaki K, Goldman H, Wong I, Wainberg MA: Viral infection of human fetal islets of Langerhans: replication of human cytomegalovirus in cultured human fetal pancreatic islets. Am J Clin Pathol 90:52-57, 1988
57. Braud VM, Tomasec P, Wilkinson GW: Viral evasion of natural killer cells during human cytomegalovirus infection. Curr Top Microbiol Immunol 269:117-129, 2002
58. Flodstrom M, Shi FD, Sarvetnick N, Ljunggren HG: The natural killer cell - friend or foe in autoimmune disease? Scand J Immunol 55:432-441, 2002
59. Chehadeh W, Weill J, Vantyghem MC, Alm G, Lefebvre J, Wattre P, Hober D: Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J Infect Dis 181:1929-1939, 2000
60. Varela-Calvino R, Ellis R, Sgarbi G, Dayan CM, Peakman M: Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes. Diabetes 51:1745-1753, 2002